Merck | MRK - Ebitda

Stock Price
109.80
Daily Change
-0.10 -0.09%
Monthly
-9.52%
Yearly
-10.15%
Q2 Forecast
106.58

Merck reported EUR1.44B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Adidas EUR 1.02B 215M Sep/2025
Adyen EUR 543.69M 19.72M Jun/2025
Akzo Nobel EUR 385M 8M Sep/2025
Alcon AG USD 317M 337M Dec/2025
Amadeus IT EUR 577.9M 74.8M Dec/2025
Amarin USD 12.54M 28.57M Jun/2025
AstraZeneca USD 5.23B 272M Sep/2025
BASF EUR 1.54B 228M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Beiersdorf EUR 984M 147M Jun/2025
Covestro EUR 242M 24M Sep/2025
Danone EUR 2.45B 149M Jun/2025
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 1.07B 142.74M Dec/2025
Galapagos EUR 2.42M 161.13M Sep/2025
Genmab DKK 186M 291M Dec/2025
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Henkel EUR 1.88B 139M Dec/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Infineon EUR 1.13B 70M Dec/2025
Linde USD 3.38B 30M Sep/2025
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 4.77B 1.11B Dec/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
UCB EUR 1.6B 570M Dec/2025